Archive

Massachusetts Cannabis Control Commission Reviewing Host Community Agreements for Compliance With New Regulations

By David Ullian, Tim Callahan
Jun 5, 2024

The Massachusetts Cannabis Control Commission is now issuing formal Requests for Information and Notices of Deficiency to license applicants, licensees, and host communities, and is requesting the submission of a compliant HCA or HCA Waiver. This process could cause delays in the initial application, license renewal, and final licensure processes. Learn more about the HCA reviews and how to request a license renewal extension in this Vicente Insights article.

Connect with Vicente LLP at the Hemp Beverage Conference and Festival in Minneapolis!

Jun 3, 2024

Join Vicente LLP in Minneapolis, Minnesota on June 7-8 for the inaugural Hemp Beverage Conference and Festival, hosted by the Hemp Beverage Alliance! Partner Michelle Bodian will participate in a panel offering state updates on hemp regulations, the farm bill and more at the conference. The festival will be held the following day, and Vicente attorneys Jason Tarasek and Michelle Bodian will attend. Schedule a meeting with us!

Your Voice Matters: Help Transfer Cannabis out of Schedule I

By Shawn Hauser
May 29, 2024

We are at a historic and critical moment for cannabis reform, as the DOJ and HHS/FDA have proposed rescheduling cannabis to Schedule III. The DEA is accepting public comments until July 22, 2024 via the Federal eRulemaking Portal, so now is the time to take action and make your voice heard!

Cannabis Rescheduling: The DEA's Proposed Rule and the Supporting OLC Opinion

By Jason Adelstone
May 21, 2024

The DEA published its proposed rule to move marijuana from schedule I to schedule III on May 21, and the 60-day public comment period has officially opened. The DEA also published an opinion from the Office of Legal counsel that provides a thorough analysis supporting why placing marijuana in schedule III is appropriate and legally justified. Read this insight for a high-level overview of the proposed rule and the OLC Opinion.

Marijuana Rescheduling Part II: Why Opponents Continue to Have No Idea What They Are Talking About

By Jason Adelstone
May 20, 2024

In a recent House Committee meeting with DEA Administrator Anne Milgram, Rep. Andrew S. Clyde voiced his opposition to removing marijuana from Schedule I based on public safety reasons, but then contradicted himself by stating marijuana is “not as dangerous as some of the others we have talked about” (the meeting focused primarily on fentanyl’s harms to communities). This blog post addresses the false narratives and misconceptions that opponents of cannabis reform continue to promote.

Vicente LLP Heads to Minneapolis for CANNRA 2024 External Stakeholder Meeting

May 16, 2024

Will you be in Minneapolis for the CANNRA 2024 External Stakeholder Meeting? Several members of the Vicente LLP team will be in attendance! Senior associate Jason Adelstone will discuss international considerations during the closing plenary on June 5, and partners Adam Fine and Michelle Bodian, director of regulatory policy Jen Flanagan, and counsel Jason Tarasek will also be in attendance!

Marijuana Rescheduling: Why Opponents Have No Idea What They Are Talking About

By Jason Adelstone
Apr 29, 2024

After listening to the House Oversight and Accountability Committee Hearing with the Commissioner of the FDA on April 11, one conclusion was reinforced—opponents of marijuana reform are misinformed and rely on misstating facts to support their position. Those against moving marijuana into schedule III are making their voices heard, but almost universally, those voices simply do not understand what schedule III would mean.

Minnesota’s Proposed Cannabis Legislation Would Provide Early-Mover Licensing Opportunities for Social Equity Business Applicants

By Jason Tarasek, Yolanda Clarke
Mar 12, 2024

Minnesota lawmakers are proposing a bill to reshape the state's adult-use cannabis market, prioritizing social equity business applicants. The bill would grant social equity applicants a head start through temporary licenses allowing them to prepare for full licensure. This Insights post highlights social equity applicant criteria, limits on the total number of cannabis business licenses, and additional details to this recently introduced bill.

Model Host Community Agreement Released by Massachusetts Cannabis Control Commission: What You Need to Know

By David M. Ullian, Tim Callahan
Mar 7, 2024

This Insights post provides an overview of recent changes impacting Massachusetts cannabis businesses. We break down the new Model Host Community Agreement (HCA), explaining its purpose, usage, and accessibility. Additionally, we explore the updated application and renewal processes, highlighting the mandatory inclusion of compliant HCAs or waivers. This blog serves as a valuable resource for both new and existing cannabis businesses seeking to navigate the evolving regulatory landscape in Massachusetts.

Minnesota Cannabis Regulators Announce Plans to Launch Adult-Use Dispensaries by Summer 2024

By Jason Tarasek
Feb 2, 2024

Minnesota dispensaries could be a reality by summer! The OCM unveiled an ambitious plan to speed up the launch, proposing temporary regulations and licensing reforms. Focusing on social equity, product availability, and education, they are streamlining the process by removing initial premise requirements, local government involvement, and even suggesting a new social equity classification. Read this Insights post for the latest update on Minnesota’s cannabis business regulations.

The DEA’s Scheduling of Marijuana: What Happens After the DEA Publishes Its Rule?

By Jason Adelstone
Jan 30, 2024

On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). Since then, the marijuana industry has waited in suspense for the DEA to make the final call as to what schedule marijuana will be placed. Read this Insights post that outlines the complex process of marijuana rescheduling in the US and outlines the key steps involved, from rule publication to review and final rule, emphasizing the critical role of stakeholder engagement in securing a Schedule III classification.

Cannabis and Hemp Developments in North Carolina

By David M. Ullian, Gabriel Amatruda
Oct 5, 2023

Public support for medical cannabis in North Carolina is quite strong and despite being one of only a few states that have legalized medical or adult use, cannabis is finally making headway in the Tar Heel State. Read this article to learn about recent cannabis and hemp developments in NC, including legislation and the Eastern Band of Cherokee Indians’ vote to legalize adult-use cannabis.

[Vicente LLP Event] Minnesota Hemp & Cannabis Seminar

Sep 18, 2023

Join the Vicente LLP team in Minneapolis for another can’t-miss hemp and cannabis legal and business seminar on October 19, 2023. The event will feature Vicente LLP hemp and cannabis business attorneys Michelle Bodian, Travis Copenhaver, Jeremy Shaw and Jason Tarasek, along with special guests Sen. Lindsey Port and cannabis accountant Angela L’Esperance of Ms. Jane Accounting.

Oklahoma Cannabis Operators Should Be Alert of Increased Enforcement and Heightened License Application Scrutiny from OMMA

By Genevieve Meehan, Emily Hackman
Jul 26, 2023

As cannabis markets mature, regulatory agencies typically increase compliance enforcement through inspections and audits. It has become increasingly clear that The Oklahoma Medical Marijuana Authority has shifted toward increased and escalated enforcement and heightened license application scrutiny. Learn more about this shift and review the updated OMMA inspection forms by reading this Insights article.

Minnesota Cannabis Market Projections

By Travis Copenhaver
Jun 22, 2023

While the state of Minnesota's study on the expected size and growth of the state's cannabis industry will not be complete until January 15, 2025, Vicente LLP's Economics & Research Department recently made some general predictions about the market. Read this Insights article to dive into the numbers.

Upcoming Cannabis Business Licensing Opportunities Across the U.S.

By Jerrico Perez
May 22, 2023

Opportunities for growth across the nation are currently abundant for cannabis businesses, and our experienced team is here to help you navigate these increasingly complex and competitive licensing processes. With more winning merit-based applications than any other law firm in the country, our team’s work ethic, dedication, and experience will help elevate your application above the competition and set your business up for long-term success.

Revisiting SOPs in Massachusetts Cannabis: A Cautionary Tale

By Casey Leaver
Apr 10, 2023

The Massachusetts cannabis employee data breach made public last month by the Cannabis Control Commission, combined with recent announcements about the Commission’s “secret shopper” program and an increase in unannounced inspections at licensed facilities, presents a trifecta of reminders for marijuana establishments to revisit their standard operating policies and procedures (SOPs).

Minnesota Cannabis Legalization Bill Amended to Lessen Potential Impact on Breweries Manufacturing THC Beverages

By Krissy Atterholt, Jason Tarasek
Mar 22, 2023

Microbreweries and cideries have become Minnesota THC beverage market leaders in the wake of 2022's hemp-derived THC product bill. The current cannabis legalization bill would have made things difficult for these producers, but it was recently amended so that lower-potency hemp edibles manufacturers could produce lower-potency hemp edibles at the same facility where food (such as beer or cider) is manufactured.

President Biden's Cannabis Scheduling Directive: Part 3

By Shane Pennington
Nov 9, 2022

What outcomes are possible from the impending administrative process to reconsider cannabis’s schedule I status? What are the implications of those various possible outcomes? And how should we all proceed in light of it all?

President Biden's Cannabis Scheduling Directive: Part 2

By Shane Pennington
Oct 21, 2022

To appreciate the gravity of the President’s scheduling directive and what could happen next, you need to understand (1) how the administrative process the President has set in motion will actually work and (2) how the agencies in charge have used it to affirm and reaffirm cannabis’s schedule I1 status repeatedly throughout the Comprehensive Drug Abuse Prevention and Control Act of 1970’s (“CSA”) history. Those topics are covered in this article.